Biggest News Aggregation in the World
📰 Aallergic News

Page 10 - Aallergic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aallergic. Real-time updates on events, politics, business and more.

DelveInsight Business Research, LLP: Allergic Rhinitis Market Is Contemplated to Advance at a CAGR of 2.5% in the 7MM for the Study Period of 2018-30, Asserts DelveInsight

- Allergic Rhinitis Market is anticipated to grow owing to factors such as the incoming of novel and emerging potential Allergic Rhinitis treatment therapies and the contribution of pharma giants
United States United Kingdom Shruti Thakur Advagene Biopharma Fexofenadine Allegra Loratadine Claritin

Research and Markets: Europe Allergic Rhinitis Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares

The "Europe Allergic Rhinitis Market and Competitive Landscape 2021" report has been added to ResearchAndMarkets.com's offering. The latest research Europe Allergic Rhinitis Market and Competitive
United Kingdom Kostenloser Wertpapierhandel Laura Wood E St Office Hours Call Office Hours Call Research Methodology

No weight gain during pregnancy has impact on development of allergic diseases in newborns: Study

According to a study by the University of Ottawa, a mothers weight before pregnancy may impact their newborns risk of developing allergic diseases in early childhood, whereas weight gain during pregnancy did not seem to have the same effect.
Sebastian Srugo Public Health University Of Ottawa School Of Epidemiology Perinatal Epidemiology Ews India

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Altamira Therapeutics Announces Randomization of First Patient in Bentrio Trial in Seasonal Allergic Rhinitis

HAMILTON, BERMUDA / ACCESSWIRE / December 1, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection
Thomas Meyer Stephen Kilmer Securities Exchange Commission Altamira Therapeutics Ltd Securities Exchange Altamira Therapeutics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science